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Introduction
New species of Emmonsia-like fungi, with phylogenetic and clinical similarities to Blastomyces
andHistoplasma, have emerged as causes of systemic human mycoses worldwide. They differ
from classical Emmonsia species by producing a thermally-dependent, yeast-like phase rather
than adiaspores, and by causing disseminated infections, predominantly in immunocompro-
mised patients and often with high case-fatality rates. Such differences will be important for cli-
nicians to consider in diagnosis and patient management, and for microbiologists who may
encounter these fungi with increasing frequency.
Adiaspiromycosis Is a Rare and Limited Disease in Humans
Until recently, the clinical relevance of the genus Emmonsia was limited to a very rare and
unusual pulmonary disease named adiaspiromycosis, caused by two species, Emmonsia cres-
cens and Emmonsia parva. The disease follows inhalation of aerosolized conidia, released from
mycelia found in soil. In the lungs, the conidia undergo a dramatic enlargement, from ~2–
4 μm to 40–500 μm in diameter—a volume increase of up to a million-fold [1]. Emmons and
Jellison called these swollen cells adiaspores, from the Greek α– (not, without), –δια– (by,
through), and –σπορα (seed, sowing), in reference to the fact that they neither replicate nor
disseminate [1]. However, their presence in the host may provoke a foreign body reaction,
resulting in granulomatous lung disease [2,3]. Disease severity is dependent on inoculum size
and host response, with a spectrum ranging from subclinical pneumonia to diffuse pulmonary
disease causing hypoxic respiratory failure and, occasionally, death [2–4].
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Adiaspiromycosis is common in rodents and other small terrestrial mammals. For instance,
nearly a third of wild British mammals sampled had signs of the disease [5]. E. crescens has
been reported to cause adiaspiromycosis in over 118 mammalian species with a global distribu-
tion [2]. Sequencing data from some E. parva-like isolates from animals has implicated differ-
ent, as-yet-undescribed species (e.g., Emmonsia sp. from weasels in the United States [6] and
Emmonsia sp. from mustelid in the Czech Republic), which are included in the phylogenetic
tree of Fig 1.
Occasionally, humans can also be affected. The first human case of adiaspiromycosis was
reported in 1964 [7], and cases have since been reported worldwide [2,3]. E. crescens has been
implicated in the vast majority of these infections. Unusual cases of infection by E. parva have
also been reported in immunocompromised hosts [8,9]; however, clinical and histopathological
findings were so atypical that, in the absence of molecular confirmation, the identification of
the pathogen has been questioned [2,3]. Additionally, superficial adiaspiromycosis was
reported to cause granulomatous conjunctivitis in 99 of 5,084 children (1.9%) screened in the
Amazon basin, and histopathological examination of ocular nodules identified adiaspore-like
Fig 1. Maximum likelihood phylogeny inferred using RAxML v. 8.0.0 employing GTRCATmodel and 1,000 bootstrap replicates. Bootstrap branch
support above 80% is shown. Multiple sequences in the same species are collapsed. Genera included in the family Ajellomycetaceae are shown, with the
exception of Lacazia loboi, which could not meaningfully be aligned.
doi:10.1371/journal.ppat.1005198.g001
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structures in two of 14 cases [10]. The investigators identified diving in a nearby river as a risk
factor, and surmised that conjunctival irritation from spicules of freshwater sponges provided
a portal of entry. However, the identification of the putative pathogen remains unclear: the
unusual exposure history and clinical features suggest that Rhinosporidium seeberi rather than
Emmonsia species might have been involved.
A Leap fromObscurity to Global Medical Importance
Over the last four decades, reports have emerged of patients with unusual mycoses: in the labo-
ratory, cultures have isolated molds with asexual reproductive structures that resembled
Emmonsia, but clinical and histopathological pictures were more compatible with blastomyco-
sis or histoplasmosis than adiaspiromycosis (Fig 2). Molecular sequencing has since confirmed
that these fungi belong to a cluster of novel Emmonsia-like species (Fig 1). It remains unclear
whether this cluster of Emmonsia-like species only emerged recently as human pathogens, or
whether previous infections were merely underestimated. Support for the latter hypothesis
comes from South Africa, where the introduction of molecular identification tools resulted in a
dramatic increase in the number of cases of disseminated Emmonsia disease, commensurate
with a decline in the number of cases of confirmed histoplasmosis [11]. The timing of human
cases is illustrated in Fig 3.
The earliest recorded case, from 1970, was reported as an unusual case of blastomycosis in a
patient from Alberta, Canada, a region considered non-endemic for this disease [12]. The
patient presented with neurological symptoms; at autopsy, histopathology sections revealed
atypical yeast-like cells in lung and brain, and a fungus resembling Blastomyces dermatitidis
was isolated from cerebral spinal fluid and lung. However, the organism failed to produce typi-
cal conidia or thick-walled yeast cells in culture [12]. Retrospective examination of the culture,
including sequencing of large ribosomal subunit and internal transcribed spacers (ITS) loci,
determined that this isolate represented a novel Emmonsia-like fungus (Emmonsia sp. 1, Fig 1)
[6].
The next recorded case of disseminated infection, in 1992, was an HIV-infected male from
Saskatchewan, Canada, with cutaneous lesions. Skin biopsy culture grew a mold resembling
Emmonsia; retrospective genetic analysis demonstrated the novelty of this species (Emmonsia
sp. 2, Fig 1) [6,13]. A second case from Saskatchewan occurred in 2003, in an Asian renal trans-
plant recipient with atypical pneumonia. An Emmonsia-like fungus was cultured from blood
and respiratory specimens [14].
A third novel Emmonsia-like fungus (Emmonsia sp. 3, Fig 1) was found in 1993, causing
granulomatous mucocutaneous lesions in an immunocompetent man in Israel [13]. The yeast-
like cells seen on skin biopsy were originally thought consistent with blastomycosis [13], but
the fungal cells were smaller, and an Emmonsia-like fungus was isolated [15]. A second case of
infection was recently identified in an immunocompetent South African patient with a mycotic
brain abscess [16]. Histopathology of brain biopsy was suggestive of blastomycosis [17], but
the ITS sequence of an Emmonsia-like fungus isolated from brain tissue was nearly identical to
that of the fungus cultured from the Israeli case [18], suggesting these isolates belong to the
same species.
In 1994, an HIV-infected woman from Italy was diagnosed with a disseminated mycosis
[19]. Biopsies of cutaneous lesions revealed small, yeast-like cells in tissue, and a thermally
dimorphic Emmonsia-like fungus was isolated in culture [19]. This was described as the
novel species E. pasteuriana (E. pasteuriana 4, Fig 1) [20]. An additional case was reported in
2011, in a liver transplant recipient with HIV infection from Spain, with pulmonary and cuta-
neous lesions [21,22]. Recently, two additional cases of E. pasteuriana were reported from
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Guangzhou, China, in a renal transplant recipient [23] and in a patient treated with high-dose
corticosteroids [24].
In 1995, a fifth novel Emmonsia-like fungus (Emmonsia sp. 5, Fig 1) was isolated from a
skin biopsy of an HIV-infected man in South Africa with widespread skin lesions [11]. The
fungus had yeast-like structures instead of adiaspores. Another case was not identified until
2008, when routine molecular identification of dimorphic fungi was adopted at several micro-
biology laboratories in South Africa. Over the next 3 years, 13 cases of disseminated disease
Fig 2. Clinical, pathological, andmycological facets of a novel Emmonsia-like fungus reported from South Africa. Top left: Hyperkeratotic skin
lesions in a patient with disseminated Emmonsia disease (published with patient consent; courtesy of Dr. Tabie Greyling, Stellenbosch University). Top right:
Peripheral blood smear showing neutrophils with multiple phagocytosed yeast-like cells (Wright-Giemsa staining x1,000). Bottom right: Electron microscopy
image of conidia (courtesy of Dr. Monica Birkhead, National Institute of Communicable Diseases). Bottom left: Light microscopy image of conidiophores and
conidia (x1,000).
doi:10.1371/journal.ppat.1005198.g002
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were diagnosed among HIV-infected adults [11]. By 2015, 55 cases had been diagnosed
[17,25]. Among these, 53 were HIV-infected, and another was a renal transplant recipient. Pul-
monary disease was common and cutaneous involvement near universal. The case fatality rate
was 48% [17].
In 2000, a sixth novel Emmonsia-like fungus (Emmonsia sp. 6, Fig 1) was implicated as the
cause of isolated, necrotizing pneumonia in a German farmer with rheumatoid arthritis treated
with corticosteroids. Yeast-like cells were present in a transbronchial biopsy [26]. And finally,
in 2005, infection due to a seventh novel Emmonsia-like fungus (Emmonsia sp. 7, Fig 1)
occurred in a diabetic patient from Beijing, China [27], who had pulmonary and cutaneous
disease.
Key Emergent Traits of Disseminated Emmonsia Disease
The newly recognized Emmonsia species differ significantly from the agents of adiaspiromyco-
sis, most notably in displaying thermal dimorphism, and growing as a mold at 25°C and as
yeast-like cells (rather than producing adiaspores) at 37°C. Consequently, major differences
exist in the pathogenesis, epidemiology, disease spectrum, diagnostic findings, course, and
management.
Fig 3. Timeline of human cases of disease caused by classical Emmonsia species (with adiaspores at 37°C) and novel Emmonsia-like species
(with yeast cells at 37°C). Vertical bars represent number of cases during 5-year intervals, as determined by literature review. The increase in cases of
diseases caused by novel Emmonsia-like species occurring between 2006 and 2015 is primarily driven by recognition of HIV-associated cases in South
Africa following the introduction of molecular identification protocols for dimorphic fungal infections in 2008.
doi:10.1371/journal.ppat.1005198.g003
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The primary route of infection, conserved among Emmonsia spp., is presumed to be inhala-
tion of airborne conidia released from saprophytic mycelia in soil [2]. Similarities in pathogen-
esis between classical and emerging Emmonsia-like species end there. Once in the mammalian
(human) host tissue, rather than swelling to sterile, static adiaspores, conidia of newer Emmon-
sia-like species convert to yeast-like cells capable of replication and extra-pulmonary dissemi-
nation. Disease results from tissue invasion [28], although a contribution of host response to
pathogenesis is suggested by apparent unmasking immune reconstitution inflammatory syn-
drome in some HIV-infected patients who develop stigmata of disease upon initiating antire-
troviral treatment [17].
Most reported patients with adiaspiromycosis have been immunocompetent [2,4], although
exceptions exist [3,4]. In contrast, nearly all reported patients with disease due to emerging
Emmonsia-like species have had profound impairment of cell-mediated immunity. These have
included HIV infection in the vast majority (among whom the median CD4+ T-lymphocyte
count was 16 cells/μL) [11,17,19,21,25]. Other associated conditions include solid organ trans-
plantation [14,16,21,23] and corticosteroid use [23,26].
Results of histopathological and microbiological investigations of adiaspiromycosis and dis-
seminated Emmonsia disease are unmistakably different. The sine qua non of adiaspiromycosis
is the presence of adiaspores in tissue; the causative agents have rarely been cultured from
humans [2,13]. On the other hand, the histopathological hallmark of disseminated Emmonsia
disease is yeast-like cells in tissue [11,12,15,17,19], which may be mistaken for Histoplasma
[17] or Blastomyces [12,15,17]. Fungi may be isolated from clinical specimens, particularly
with prolonged incubation on routine fungal culture media [2,12,14,17,19,21,23,25,26].
The natural histories of adiaspiromycosis and disseminated Emmonsia disease are quite dif-
ferent and, consequently, principles of management differ, although evidence to guide therapy
is anecdotal. Adiaspiromycosis is generally self-limiting, and fatalities are exceptional [29–31].
Because this disease results from host response, corticosteroids have been advocated in severe
cases; the role of antifungals remains uncertain [3,31,32]. In contrast, disseminated Emmonsia
disease appears to be a progressive disease in many patients, particularly immunocompromised
hosts, in whom case-fatality rates approach 50%; among these patients, antifungals appear to
be imperative [17].
Disentangling the Ajellomycetaceae
Even before the discovery of newer Emmonsia spp., the taxonomy of these species was a matter
of debate among mycologists [2,33]. The sexual stage (teleomorph) of E. crescens belongs to
Ajellomyces, the same genus as the teleomorphs of B. dermatitidis andH. capsulatum [34], sug-
gesting a close relatedness. Genetic studies have also demonstrated a close phylogenetic rela-
tionship between Emmonsia and Blastomyces [13,35]; in fact, E. parva is more closely related to
Blastomyces than to E. crescens [13]. Members of both genera produce budding, yeast-like cells
and share genetic similarities, perhaps even justifying the assignment of Blastomyces and
Emmonsia species to a single genus [13,35,36]. Full genome sequencing of multiple isolates of
all Emmonsia-like species will provide greater resolution of phylogenetic relationships, and
may help to clarify taxonomic boundaries. Recently, genome sequences for two animal-associ-
ated Emmonsia strains were made publicly available in NCBI (isolated from lungs of a rodent
and from a weasel, and catalogued under Bioprojects PRJNA178252 and PRJNA178178,
respectively), and submissions are in progress for additional human-associated, pathogenic
strains shown in Fig 1. Preliminary phylogenetic analyses suggest that most of the new human-
associated Emmonsia-like fungi form a single, derived clade in the Ajellomycetaceae, while
agents of adiaspiromycosis appear to be polyphyletic (Fig 1).
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